↓ Skip to main content

American College of Cardiology

Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry

Overview of attention for article published in JACC: Heart Failure, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
3 news outlets
twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
58 Mendeley
Title
Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry
Published in
JACC: Heart Failure, February 2016
DOI 10.1016/j.jchf.2015.12.003
Pubmed ID
Authors

Nish Patel, Christine Ju, Conrad Macon, Udho Thadani, Phillip J. Schulte, Adrian F. Hernandez, Deepak L. Bhatt, Javed Butler, Clyde W. Yancy, Gregg C. Fonarow

Abstract

The aim of this study was to assess temporal trends and factors associated with digoxin use at discharge among patients admitted with heart failure (HF). Digoxin has class IIa recommendations for treating HF with reduced ejection fraction (HFrEF) in the United States. Digoxin use, temporal trends, and clinical characteristics of HF patients in current clinical practice in the United States have not been well studied. An observational analysis of 255,901 patients hospitalized with HF (117,761 with HFrEF and 138,140 with preserved EF [HFpEF]) from 398 hospitals participating in the Get With The Guidelines-HF registry between January 2005 and June 2014 was conducted to assess the temporal trends and factors associated with digoxin use. Among 117,761 HFrEF patients, only 19.7% received digoxin at discharge. Digoxin prescriptions decreased from 33.1% in 2005 to 10.7% in 2014 (ptrend < 0.0001). Factors associated with digoxin use in HFrEF included atrial fibrillation (AF) (odds ratio [OR]: 2.14; 95% confidence intervals [CI]: 2.02 to 2.28), history of implantable cardioverter defibrillator use (OR: 1.39; 95% CI: 1.32 to 1.46), chronic obstructive pulmonary disease (OR: 1.13, 95% CI: 1.08 to 1.18), diabetes mellitus (OR: 1.10, 95% CI: 1.06 to 1.14), younger age (OR: 0.96, 95% CI: 0.95 to 0.97), lower blood pressure (OR: 0.96, 95% CI: 0.96 to 0.97), and having no history of renal insufficiency (OR: 0.91, 95% CI: 0.85 to 0.97). Use of digoxin in patients with HFpEF (n = 138,140) without AF was 9.8% in 2005, which decreased to 2.2% in 2014 (ptrend < 0.0001). One in 5 HFrEF patients received digoxin at discharge, with a significant downward temporal trend in use over the study period. Use of digoxin in HFpEF patients without AF was very low and decreased over the study period.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 16%
Researcher 9 16%
Student > Bachelor 7 12%
Student > Master 5 9%
Student > Ph. D. Student 4 7%
Other 10 17%
Unknown 14 24%
Readers by discipline Count As %
Medicine and Dentistry 20 34%
Nursing and Health Professions 5 9%
Biochemistry, Genetics and Molecular Biology 3 5%
Agricultural and Biological Sciences 2 3%
Psychology 2 3%
Other 7 12%
Unknown 19 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2019.
All research outputs
#1,551,664
of 25,394,764 outputs
Outputs from JACC: Heart Failure
#482
of 1,584 outputs
Outputs of similar age
#27,718
of 410,116 outputs
Outputs of similar age from JACC: Heart Failure
#8
of 37 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,584 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 410,116 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.